Under the terms of the agreement, Kyorin will receive $55m upfront and will be eligible for milestone payments of up to ...

Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential capital increase, a regulatory source ...

despite a mid-stage stroke trial miss – as well as Anthos Therapeutics with abelacimab, an injectable Factor XI/XIa-targeting antibody that generated encouraging results in a phase 2b trial ...

as well as Anthos Therapeutics with abelacimab, an injectable Factor XI/XIa-targeting antibody that generated encouraging results in a phase 2b trial earlier this year. Milvexian is in three late ...

Exclusive: Bayer share drop draws market regulator's scrutiny, source says Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get ...

22kg manuscript is being loaned for three months to the Jura Museum of Art and History A journalist looks at the Moutier-Grandval Bible, a 9th century illustrated bible, one of the oldest fully ...

Shareholders approved 28th consecutive dividend increase to CHF 3.50 (+6.1%) per share for 2024, representing a 3.5% yield¹ Shareholders elected Giovanni Caforio as new member and Chair of the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: March 12 at 7:46:03 PM EDT ...